Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide

Vaccine

Volumn 25, Issue 46, 2007, Pages 7972-7980

  Gudlavalleti, Seshu K ^a   Lee, Che Hung ^a   Norris, Scott E ^a   Paul Satyaseela, Maneesh ^a   Vann, Willie F ^a   Frasch, Carl E ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Conjugate vaccines; Neisseria meningitidis serogroup W135; Polysaccharide O acetylation

Indexed keywords

GALACTOSE; HYDRAZINE; PERIODATE; POLYSACCHARIDE TETANUS TOXOID CONJUGATE VACCINE; TETANUS TOXOID; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BACTERIAL STRAIN; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGENICITY; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; OXIDATION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TITRIMETRY;

ACETYLATION; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; BLOOD BACTERICIDAL ACTIVITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; HYDROLYSIS; MENINGOCOCCAL INFECTIONS; MICE; NEISSERIA MENINGITIDIS, SEROGROUP W-135; OXIDATION-REDUCTION; PERIODIC ACID; POLYSACCHARIDES, BACTERIAL; TETANUS TOXOID; VACCINES, CONJUGATE;

EID: 35448949206     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.06.018     Document Type: Article

References (25)

1. Decosas J., and Koama J.B. Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso. Lancet Infect Dis 2 12 (2002) 763-765
2. Mayer L.W., Reeves M.W., Al-Hamdan N., Sacchi C.T., Taha M.K., Ajello G.W., et al. Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electrophoretic type-37 complex. J Infect Dis 185 11 (2002) 1596-1605
3. Taha M.K., Parent Du Chatelet I., Schlumberger M., Sanou I., Djibo S., de Chabalier F., et al. Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger. J Clin Microbiol 40 3 (2002) 1083-1084
4. Frasch C.E. Recent developments in Neisseria meningitidis group A conjugate vaccines. Expert Opin Biol Ther 5 2 (2005) 273-280
5. Zimmer S.M., and Stephens D.S. Meningococcal conjugate vaccines. Expert Opin Pharmacother 5 4 (2004) 855-863
6. Bhattacharjee A.K., Jennings H.J., Kenny C.P., Martin A., and Smith I.C. Structural determination of the polysaccharide antigens of Neisseria meningitidis serogroups Y, W-135, and BO1. Can J Biochem 54 1 (1976) 1-8
7. Longworth E., Fernsten P., Mininni T.L., Vogel U., Claus H., Gray S., et al. O-Acetylation status of the capsular polysaccharides of serogroup Y and W135 meningococci isolated in the UK. FEMS Immunol Med Microbiol 32 2 (2002) 119-123
8. Jones C., and Lemercinier X. Use and validation of NMR assays for the identity and O-acetyl content of capsular polysaccharides from Neisseria meningitidis used in vaccine manufacture. J Pharm Biomed Anal 30 4 (2002) 1233-1247
9. WHO. Requirement for meningococcal polysaccharide vaccine (Requirements for Biological substances No.23) Addendum 1980, TRS 658, Annexure 6; 1980.
10. Michon F., Huang C.H., Farley E.K., Hronowski L., Di J., and Fusco P.C. Structure activity studies on group C meningococcal polysaccharide-protein conjugate vaccines: effect of O-acetylation on the nature of the protective epitope. Dev Biol (Basel) 103 (2000) 151-160
11. Arakere G., and Frasch C.E. Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccines and carriers. Infect Immun 59 12 (1991) 4349-4356
12. Berry D.S., Lynn F., Lee C.H., Frasch C.E., and Bash M.C. Effect of O-acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses. Infect Immun 70 7 (2002) 3707-3713
13. Giardina P.C., Longworth E., Evans-Johnson R.E., Bessette M.L., Zhang H., Borrow R., et al. Analysis of human serum immunoglobulin G against O-acetyl-positive and O-acetyl-negative serogroup W135 meningococcal capsular polysaccharide. Clin Diagn Lab Immunol 12 5 (2005) 586-592
14. Jin Z., Bohach G.A., Shiloach J., Norris S.E., Freedberg D.I., Deobald C., et al. Conjugates of group A and W135 capsular polysaccharides of Neisseria meningitidis bound to recombinant Staphylococcus aureus enterotoxin C1: preparation, physicochemical characterization, and immunological properties in mice. Infect Immun 73 12 (2005) 7887-7893
15. Frasch C.E. Production and control of Neisseria meningitidis vaccines. Adv Biotechnol Process 13 (1990) 123-145
16. Hestrin S. The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine and its analytical application. J Biol Chem 180 (1949) 249-261
17. Svennerholm L. Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim Biophys Acta 24 3 (1957) 604-611
18. Jin Z., Chu C., Robbins J.B., and Schneerson R. Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice. Infect Immun 71 9 (2003) 5115-5120
19. Carroll N.V., Longley R.W., and Roe J.H. The determination of glycogen in liver and muscle by use of anthrone reagent. J Biol Chem 220 2 (1956) 583-593
20. Kao G., and Tsai C.M. Quantification of O-acetyl, N-acetyl and phosphate groups and determination of the extent of O-acetylation in bacterial vaccine polysaccharides by high-performance anion-exchange chromatography with conductivity detection (HPAEC-CD). Vaccine 22 3-4 (2004) 335-344
21. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 1 (1951) 265-275
22. Maslanka S.E., Gheesling L.L., Libutti D.E., Donaldson K.B., Harakeh H.S., Dykes J.K., et al. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group. Clin Diagn Lab Immunol 4 2 (1997) 156-167
23. Harrison L.H. Prospects for vaccine prevention of meningococcal infection. Clin Microbiol Rev 19 1 (2006) 142-164
24. Gudlavalleti S.K., Datta A.K., Tzeng Y.L., Noble C., Carlson R.W., and Stephens D.S. The Neisseria meningitidis serogroup A capsular polysaccharide O-3 and O-4 acetyltransferase. J Biol Chem 279 41 (2004) 42765-42773
25. Claus H., Borrow R., Achtman M., Morelli G., Kantelberg C., Longworth E., et al. Genetics of capsule O-acetylation in serogroup C, W-135 and Y meningococci. Mol Microbiol 51 1 (2004) 227-239